Philadelphia Transit Agency Sues Gilead Over Cost of Sovaldi
Thursday, December 11, 2014 - 00:50
in Mathematics & Economics
The lawsuit says the high price of the treatment, $1,000 per pill, results in “unjust enrichment” for the drugmaker, violating antitrust law.